Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 942 results for "aurobindo"

43 images for aurobindo

Business Standard, 1 week ago
Money Control, 1 week ago
AhmedabadMirror.com, 1 week ago
India Infoline, 6 days ago
NewsReality.com, 1 week ago
NewsReality.com, 1 week ago
Malta Independent Daily, 3 weeks ago
NDTV Profit, 1 month ago
Money Today, 1 month ago
Times of Malta, 3 weeks ago

Sell Aurobindo Pharma with a target of Rs 1,100: Ashwani Gujral

In a chat with ET Now, Ashwani Gujral, Fund Manager, Ashwanigujral.com, shares his view on Tata Steel. ET Now: What is your view on Tata Steel? Ashwani Gujral: Aurobindo Pharma is a 'SELL' call with a target of Rs 1,100 and a stop loss of Rs 1,160. DON'T MISS ...
 Economic Times9 hours ago Buy Aurobindo Pharma with a target of Rs 1,240: Ashwani Gujral  Economic Times1 day ago Prefer Aurobindo Pharma, target Rs 1315: Manish Hathiramani  Money Control1 week ago Mkt eager for passage of key bills; buy Britannia: Bodke  Money Control2 weeks ago
[x]  

Avoid pharma stocks: Sudarshan Sukhani

"Even Sun Pharma is showing signs of exhaustion. Lupin is doing that, Aurobindo Pharma is doing that and so for traders again pharma is an avoid but don't short it,"
 Moneycontrol.com3 days ago Buy pharma stocks: Sudarshan Sukhani  Moneycontrol.com1 week ago

Buy Aurobindo Pharma, says Rahul Mohindar

Rahul Mohindar of viratechindia.com recommends buying Aurobindo Pharma.
 Money Control2 days ago Buy Aurobindo Pharma 1100 Call, says Rahul Shah  Money Control3 weeks ago Buy Aurobindo Pharma 1240 Call, says VK Sharma  Money Control1 month ago Buy Auro Pharma 1100 Call, sell 1150 Call: Gaurav Bissa  Money Control3 weeks ago
India Infoline

Aurobindo Pharma stock ends 1% lower after hitting record high

Lacosamide Tablets are the generic equivalent of USB Inc’s Vimpat Tablets and used in the treatment of partial-onset seizures in patients with epilepsy aged 17 years and older with a market size of approximately US$ 593 Million for the twelve months ending ...
 India Infoline6 days ago Aurobindo Pharma receives US FDA tentative approval for Lacosamide tabs  Financial Express6 days ago Aurobindo gets tentative US FDA nod for Lacosamide tablets  Smart Investor1 week ago Aurobindo gets US FDA nod for Lacosamide tablets  Hindu Business Line1 week ago
[x]  
Business Standard

Aurobindo Pharma: Regaining traction

Aurobindo Pharma after correcting about 20% from Rs 1,264 in February has pared a large part of the loss, closing at Rs 1,221 on Tuesday. The correction was due to some disappointment on the margin front in the December'14 quarter, US FDA ...
 Business Standard India1 week ago Aurobindo Pharma stock hits 5% lower circuit  India Infoline1 month ago Board of Aurobindo Pharma recommends dividend  Business Standard1 month ago Aurobindo Pharma slips 4%  India Infoline1 month ago
[x]  
Business Standard

Aurobindo Pharma hits record high on USFDA tentative nod for Lacosamide tablets

Related to : Aurobindo Pharma Ltd Aurobindo Pharma Ltd BSE 19 Mar 15 | 03:05 PM 1239.30 -3.05 (-0.25%) NSE 19 Mar 15 | 02:54 PM 1251.00 6.05 (0.49%) Shares of Aurobindo Pharma were trading higher by 2% at Rs 1,265 on the BSE ...
 Smart Investor1 week ago Aurobindo Pharma gains on USFDA nod for hypertension drug  Business Standard2 months ago
[x]  
India Infoline

Lupin, Rajesh Exports amongst top gainers

A total of 38 stocks touched a fresh 52-week high on BSE today. Prominent among these were — Aurobindo Pharma, Bosch, Dabur India, Elecon Engineering, Gillette India, GSK Healthcare, Hitachi Home and Life Solutions, HSIL, Kalyani Investment ...
 India Infoline1 week ago

Valuations of Aurobindo Pharma cheaper than many fronline peers; further upside likely: Anand Tondon

In a chat with ET Now, Anand Tandon, an independent analyst, shares his view on Aurobindo Pharma. ET Now: We have an exclusive news. Sources have indicated that the US FDA has cleared company's unit IV and V in the re-inspection which generates ...
 Economic Times1 week ago

Buy Voltas, Aurobindo Pharma, Havells: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com recommends buying Voltas, Aurobindo Pharma and Havells India.
 Money Control2 weeks ago Buy Ashok Leyland, prefer Aurobindo Pharma: Sukhani  Money Control2 weeks ago See opportunity in Sun pharma, Lupin: Sudarshan Sukhani  Money Control2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - aurobindo
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less